Your browser doesn't support javascript.
loading
A novel phenotype of AChR-deficiency syndrome with predominant facial and distal weakness resulting from the inclusion of an evolutionary alternatively-spliced exon in CHRNA1.
Rodríguez Cruz, Pedro M; Ravenscroft, Gianina; Natera, Daniel; Carr, Aisling; Manzur, Adnan; Liu, Wei Wei; Vella, Norbert R; Jericó, Ivonne; Gonzalez-Quereda, Lidia; Gallano, Pia; Montalto, Simon Attard; Davis, Mark R; Lamont, Phillipa J; Laing, Nigel G; Bourque, Pierre; Nascimento, Andres; Muntoni, Francesco; Polavarapu, Kiran; Lochmüller, Hanns; Palace, Jacqueline; Beeson, David.
Afiliação
  • Rodríguez Cruz PM; CNAG-CRG, Centro Nacional de Análisis Genómico - Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain. Electronic address: pedro.rodriguez@cnag.crg.eu.
  • Ravenscroft G; Harry Perkins Institute of Medical Research, Nedlands, WA, Australia; Centre of Medical Research, University of Western Australia, Nedlands, WA, Australia.
  • Natera D; Neuromuscular Unit, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Carr A; Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
  • Manzur A; Dubowitz Neuromuscular Centre, NIHR Biomedical Research Centre, UCL Great Ormond Street Institute of Child Health; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Liu WW; Neurosciences Group, Weatherall Institute of Molecular Medicine, University of Oxford, The John Radcliffe Hospital, Oxford, UK.
  • Vella NR; Department of Neuroscience, Mater Dei Hospital, Msida, Malta.
  • Jericó I; Department of Neurology, Hospital Universitario de Navarra, IdisNa (Instituto Investigación Sanitaria Navarra), Pamplona, Spain.
  • Gonzalez-Quereda L; Center for the Biomedical Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain; Department of Genetics, Hospital de Sant Pau, IIB Sant Pau, Barcelona, Spain.
  • Gallano P; Center for the Biomedical Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain; Department of Genetics, Hospital de Sant Pau, IIB Sant Pau, Barcelona, Spain.
  • Montalto SA; Department of Paediatrics, Mater Dei Hospital, Msida, Malta.
  • Davis MR; Neurogenetic Unit, Department of Diagnostic Genomics, PathWest Laboratory Medicine, Western Australian Department of Health, Nedlands, WA, Australia.
  • Lamont PJ; Department of Neurology, Royal Perth Hospital, Nedlands, WA, Australia.
  • Laing NG; Harry Perkins Institute of Medical Research, Nedlands, WA, Australia; Centre of Medical Research, University of Western Australia, Nedlands, WA, Australia; Neurogenetic Unit, Department of Diagnostic Genomics, PathWest Laboratory Medicine, Western Australian Department of Health, Nedlands, WA, Austr
  • Bourque P; Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada.
  • Nascimento A; Neuromuscular Unit, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Muntoni F; Dubowitz Neuromuscular Centre, NIHR Biomedical Research Centre, UCL Great Ormond Street Institute of Child Health; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Polavarapu K; Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada.
  • Lochmüller H; CNAG-CRG, Centro Nacional de Análisis Genómico - Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain; Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada; Division of Neurology, Department of Medicine, The Ottawa
  • Palace J; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Beeson D; Neurosciences Group, Weatherall Institute of Molecular Medicine, University of Oxford, The John Radcliffe Hospital, Oxford, UK; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Neuromuscul Disord ; 33(2): 161-168, 2023 02.
Article em En | MEDLINE | ID: mdl-36634413
ABSTRACT
Primary acetylcholine receptor deficiency is the most common subtype of congenital myasthenic syndrome, resulting in reduced amount of acetylcholine receptors expressed at the muscle endplate and impaired neuromuscular transmission. AChR deficiency is caused mainly by pathogenic variants in the ε-subunit of the acetylcholine receptor encoded by CHRNE, although pathogenic variants in other subunits are also seen. We report the clinical and molecular features of 13 patients from nine unrelated kinships with acetylcholine receptor deficiency harbouring the CHRNA1 variant NM_001039523.3c.257G>A (p.Arg86His) in homozygosity or compound heterozygosity. This variant results in the inclusion of an alternatively-spliced evolutionary exon (P3A) that causes expression of a non-functional acetylcholine receptor α-subunit. We compare the clinical findings of this group to the other cases of acetylcholine receptor deficiency within our cohort. We report differences in phenotype, highlighting a predominant pattern of facial and distal weakness in adulthood, predominantly in the upper limbs, which is unusual for acetylcholine receptor deficiency syndromes, and more in keeping with slow-channel syndrome or distal myopathy. Finally, we stress the importance of including alternative exons in variant analysis to increase the probability of achieving a molecular diagnosis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Nicotínicos / Síndromes Miastênicas Congênitas Limite: Humans Idioma: En Revista: Neuromuscul Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Nicotínicos / Síndromes Miastênicas Congênitas Limite: Humans Idioma: En Revista: Neuromuscul Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article